NEWS
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
PRNewswire
2026/01/07ContractsBayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization News provided by Cradle Jan 07, 2026, 07:00 ET Share this article Share to X Share this article Share to X Bayer Cradle (PRNewsfoto/Cradle)
Summary
Cradle provides a scientific AI software platform focused on protein engineering Bayer continues to utilize AI in R&D, reinforcing commitment to modernize and scale its drug discovery and development efforts Bayer and Cradle to jointly work on a machine learning research project to...